Page 1 of 1INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.1. Company Name and Address4. EPA ProductRegistrationOMB Approval 2070-174United States Environmental ProtectionAgency Washington, D.C. 20460DATA CALL-IN RESPONSE3. Date and Type of DCI and NumberPRODUCT SPECIFIC11-Aug-2015ID # PDCI-107403-305412. Case # and NameChemical # and Name1074031-Octadecanaminium,N,N-dimethyl-N-[3-(trihydroxysilyl)p5. I wish tocancel thisproduct registration voluntarily6. Generic Data7. Product Specific Data7a. My product is an MUP andI agree to satisfy the MUPrequirements on the attachedform entitled "RequirementsStatus and Registrant'sResponse."7b. My product is an EUP andI agree to satisfy the EUPrequirements on the attachedform entitled "RequirementsStatus and Registrant'sResponse."6a. I am claiming a GenericData Exemption because Iobtain the active ingredientfrom the source EPA registration number listed below.6b. I agree to satisfy GenericData requirements as indicatedon the attached form entitled"Requirements Status andRegistrant's Response."10. Name of Company11. Phone Number9. Date8. Certification I certify that the statements made on thisform and all attachments are true, accurate, and complete. I acknowledge that anyknowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law.Signature and Title of Company'sAuthorized Representative__________________________________INSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 1 of 4OMB Approval 2070-174United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #PRODUCT SPECIFIC11-Aug-2015PDCI-107403-305412. Case # and Name8. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321Product Chemistry Data Requirements (Antimicrobial)(1)830.15508EP; MP; TGAIProduct Identity and compositionU, T, XN(2)830.16008EP; MP; TGAIDescription of materials used to produce the productU, T, XN(3)830.16208EP; TGAIDescription of production processU, T, XN(4)830.16508EP; MP; TGAIDescription of formulation processU, T, XN(5)830.16708EP; MP; TGAIDiscussion of formation of impuritiesU, T, XN(6)830.17008EP; MP; TGAIPreliminary analysisU, T, XN830.17508EP; MP; TGAICertified limitsU, T, XN830.18008EP; MP; TGAIEnforcement analytical methodU, T, XN(7)830.63028MP; TGAIColorU, T, XN(8)830.63038EP; MP; TGAIPhysical stateU, T, XN(9)830.63048MP; TGAIOdorU, T, XN12. Name of Company13. Phone NumberSignature and Title of Company'sAuthorized Representative__________________________________10. Certification I certify that the statements made on this form and all attachments are true, accurate, and complete. Iacknowledge that anyknowingly false or misleading statement may be punishable by fine, imprisonment or both under applicable law11. DateINSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 2 of 4OMB Approval 2070-174United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #PRODUCT SPECIFIC11-Aug-2015PDCI-107403-305412. Case # and Name8. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321(10)830.63138TGAIStability to normal and elevated temperatures,metals, and metal ionsU, T, XN(11)830.63148EP; MP; TGAIOxidizing or reducing actionU, T, XN(12)830.63158EP; MPFlammabilityU, T, XN(13)830.63168EP; MPExplodabilityU, T, XN(14)830.631716EP; MPStorage stabilityU, T, XN(15)830.63198EP; MPMiscibilityU, T, XN(16)830.632016EP; MPCorrosion characteristicsU, T, XN(17)830.63218EPDielectric breakdown voltageU, T, XN(18)830.70008EP; MP; TGAIpHU, T, XN(19)830.70508TGAIUV/Visible absorptionU, T, XN(20)830.71008EP; MPViscosityU, T, XN(21)830.72008TGAIMelting point/melting rangeU, T, XNInitial to indicate certificationas to information on this page (fulltext of certification is on page one).DateINSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 3 of 4OMB Approval 2070-174United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #PRODUCT SPECIFIC11-Aug-2015PDCI-107403-305412. Case # and Name8. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321(22)830.72208TGAIBoiling point/boiling rangeU, T, XN(23)830.73008EP; MP; TGAIDensity/relative densityU, T, XN(24)830.73708TGAIDissociation constants in waterU, T, XN(25)830.75508TGAIPartition coefficient (n-octanol/water), shake flaskmethodU, T, XN(26)830.75608TGAIPartition coefficient (n-octanol/water), generatorcolumn methodU, T, XN(27)830.75708TGAIPartition coefficient (n-octanol/water), estimation byliquid chromatographyU, T, XN(28)830.78408TGAIWater solubility: Column elution method, shake flaskmethodU, T, XN(29)830.78608TGAIWater solubility, generator column methodU, T, XN(30)830.79508TGAIVapor pressureU, T, XNToxicology Data Requirements (Antimicrobial)870.11008EP; MP; TGAIAcute Oral ToxicityU, T, XNInitial to indicate certificationas to information on this page (fulltext of certification is on page one).DateINSTRUCTIONS: Please type or print in ink. Please read carefully the attached instructions and supply the information requested on this form.Use additional sheet(s) if necessary.4. GuidelineRequirementNumber5. Study Title1. Company Name and AddressPage 4 of 4OMB Approval 2070-174United States Environmental ProtectionAgency Washington, D.C. 20460REQUIREMENTS STATUS AND REGISTRANT'S RESPONSE3. Date and Type of DCI and NumberID #PRODUCT SPECIFIC11-Aug-2015PDCI-107403-305412. Case # and Name8. TimeFrame(Months)9. RegistrantResponse7. TestSubstance6. UsePatternPROTOCOLProgressReports321(31)870.12008EP; MP; TGAIAcute dermal toxicityU, T, XN870.13008EP; MP; TGAIAcute inhalation toxicityU, T, XN(33)870.25008EP; MP; TGAIAcute dermal irritationU, T, XN(34)870.26008EP; MP; TGAISkin sensitizationU, T, XN(32)870.24008EP; MP; TGAIAcute eye irritationU, T, XN(35)810.21008EPSterilantsU, T, XN(36)810.22008EPDisinfectants for Use on Hard SurfacesU, T, XN(37)810.23008EPSanitizers for Use on Hard SurfacesU, T, XN(38)810.24008EPDisinfectants and Sanitizers for Use on Fabrics andTextilesU, T, XN(39)810.25008EPAir SanitizersU, T, XN(40)810.26008EPDisinfectants for Use in WaterU, T, XNInitial to indicate certificationas to information on this page (fulltext of certification is on page one).DateThe following footnotes are referenced in column two (5. Study Title) of the Requirements Status and Registrant's Response form. These footnotes apply in addition to anytest notes included in 40 CFR Part 158 with respect to the particular data requirementCase # and Name:DCI Number:PDCI-107403-30541Page 1 of 5Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSEP; MP; TGAI = End Use Product; Manufacturing Use Product; Technical Grade Active Ingredient; MP; TGAI = Manufacturing Use Product; Technical Grade Active Ingredient; EP; MP = End UseProduct, Manufacturing Use Product; EP = End Use Product [EP]; TGAI = Technical Grade Active Ingredient [TGAI]; EP; TGAI = EndUse Product; Technical Grade Active IngredientUse Categories Key:T -U -X -Commercial, institutional and indResidential and public access prMaterials preservatives1The Confidential Statement of Formula (CSF) form may be referenced2In addition to guideline information, providing the MSDS for each component in formulation is recommended3Waiver may be requested if the product is a non-integrated system4Providing a flow chart for the formulation process is recommended.5Waiver may be requested if the product is a non-integrated system.6Waiver may be requested if the product is a non-integrated system.For an integrated system, a five batch analysis is preferred. The analysis must be based on the product to assay the active ingredient (AI). If the product is solely AI, then the certificate ofanalysis (COA) may be used in place of the five batch analysis. A COA for each supplier must be provided.7The method that was used must be provided.Provide the temperature when the study was conducted.8The method that was used must be provided.Provide the temperature when the study was conducted.9The method that was used must be provided.Provide the temperature when the study was conducted.10The method that was used must be provided.Provide the temperature when the study was conducted.11The method that was used must be provided.Provide the temperature when the study was conducted.The following footnotes are referenced in column two (5. Study Title) of the Requirements Status and Registrant's Response form. These footnotes apply in addition to anytest notes included in 40 CFR Part 158 with respect to the particular data requirementCase # and Name:DCI Number:PDCI-107403-30541Page 2 of 5Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSEP; MP; TGAI = End Use Product; Manufacturing Use Product; Technical Grade Active Ingredient; MP; TGAI = Manufacturing Use Product; Technical Grade Active Ingredient; EP; MP = End UseProduct, Manufacturing Use Product; EP = End Use Product [EP]; TGAI = Technical Grade Active Ingredient [TGAI]; EP; TGAI = EndUse Product; Technical Grade Active IngredientUse Categories Key:T -U -X -Commercial, institutional and indResidential and public access prMaterials preservatives12The method that was used must be provided.Provide the temperature when the study was conducted.13The method that was used must be provided.Provide the temperature when the study was conducted.14The method that was used must be provided.Provide the temperature when the study was conducted.Accelerated (temperature between 40 to 55 oC) storage stability can be reported to be equivalent to this guideline as long as: the AI meets the EPA Standard Certified Limits; data must bereported at the initial, in between, and at the end of the study for 14 or 30 days. If the study does not pass, then the applicant must conduct the one-year study at room temperature.The 16-month deadline for submission of this study applies if you are conducting a new study to satisfy this requirement. You are then required to submit a progress report to the Agency within 3months following the 90-Day response deadline for this PDCI. Further information appears on page 7 of the Generic and Product Specific Data Call-In Notice. If you intend to submit an existingstudy or cite previously submitted data, they must be submitted with your 90-Day Response. Alternatively, a combined, abbreviated, non-guideline, 14-day study at elevated temperatures maybe conducted and, if found acceptable, may be used to replace the one-year study.15The method that was used must be provided.Provide the temperature when the study was conducted.16The method that was used must be provided.Provide the temperature when the study was conducted.An accelerated equivalent study may be conducted in conjunction with 830.6317.The 16-month deadline for submission of this study applies if you are conducting a new study to satisfy this requirement. You are then required to submit a progress report to the Agency within 3months following the 90-Day response deadline for this PDCI. Further information appears on page 7 of the Generic and Product Specific Data Call-In Notice. If you intend to submit an existingstudy or cite previously submitted data, they must be submitted with your 90-Day Response. Alternatively, a combined, abbreviated, non-guideline, 14-day study at elevated temperatures maybe conducted and, if found acceptable, may be used to replace the one-year study.17The method that was used must be provided.Provide the temperature when the study was conducted.Waiver may be requested if the product is not intended to be use near electric outlet.The following footnotes are referenced in column two (5. Study Title) of the Requirements Status and Registrant's Response form. These footnotes apply in addition to anytest notes included in 40 CFR Part 158 with respect to the particular data requirementCase # and Name:DCI Number:PDCI-107403-30541Page 3 of 5Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSEP; MP; TGAI = End Use Product; Manufacturing Use Product; Technical Grade Active Ingredient; MP; TGAI = Manufacturing Use Product; Technical Grade Active Ingredient; EP; MP = End UseProduct, Manufacturing Use Product; EP = End Use Product [EP]; TGAI = Technical Grade Active Ingredient [TGAI]; EP; TGAI = EndUse Product; Technical Grade Active IngredientUse Categories Key:T -U -X -Commercial, institutional and indResidential and public access prMaterials preservatives18The method that was used must be provided.Provide the temperature when the study was conducted.The value must be reflected on the CSF form.19The method that was used must be provided.Provide the temperature when the study was conducted.20The method that was used must be provided.Provide the temperature when the study was conducted.21The method that was used must be provided.Provide the temperature when the study was conducted.22The method that was used must be provided.Provide the temperature when the study was conducted.23The method that was used must be provided.Provide the temperature when the study was conducted.The value must be reflected on the CSF form.24The method that was used must be provided.Provide the temperature when the study was conducted.25The method that was used must be provided.Provide the temperature when the study was conducted.26The method that was used must be provided.Provide the temperature when the study was conducted.27The method that was used must be provided.Provide the temperature when the study was conducted.The following footnotes are referenced in column two (5. Study Title) of the Requirements Status and Registrant's Response form. These footnotes apply in addition to anytest notes included in 40 CFR Part 158 with respect to the particular data requirementCase # and Name:DCI Number:PDCI-107403-30541Page 4 of 5Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSEP; MP; TGAI = End Use Product; Manufacturing Use Product; Technical Grade Active Ingredient; MP; TGAI = Manufacturing Use Product; Technical Grade Active Ingredient; EP; MP = End UseProduct, Manufacturing Use Product; EP = End Use Product [EP]; TGAI = Technical Grade Active Ingredient [TGAI]; EP; TGAI = EndUse Product; Technical Grade Active IngredientUse Categories Key:T -U -X -Commercial, institutional and indResidential and public access prMaterials preservatives28The method that was used must be provided.Provide the temperature when the study was conducted.29The method that was used must be provided.Provide the temperature when the study was conducted.30The method that was used must be provided.Provide the temperature when the study was conducted.31Waiver may be requested if test material is corrosive to skin or has pH < 2 or >11.5; such product will be classified as Toxicity Category 1 on the basis of potential dermal toxicity.32Waiver may be requested if test material is corrosive to skin or has pH < 2 or >11.5; such product will be classified as Toxicity Category 1 on the basis of potential eye irritation.33Waiver may be requested if test material is corrosive to skin or has pH < 2 or >11.5; such product will be classified as Toxicity Category 1 on the basis of potential dermal irritation.34Waiver may be requested if test material is corrosive to skin or has pH < 2 or >11.5; such product will be classified as a dermal sensitizer.35Refer to the Product Performance Test Guideline 810.2000 (general considerations for testing antimicrobial products) and the reregistration efficacy guidance document athttp://www.epa.gov/oppad001/reregistration-efficacy-standards.pdf for additional information.36Refer to the Product Performance Test Guideline 810.2000 (general considerations for testing antimicrobial products) and the reregistration efficacy guidance document athttp://www.epa.gov/oppad001/reregistration-efficacy-standards.pdf for additional information.37Refer to the Product Performance Test Guideline 810.2000 (general considerations for testing antimicrobial products) and the reregistration efficacy guidance document athttp://www.epa.gov/oppad001/reregistration-efficacy-standards.pdf for additional information.38Refer to the Product Performance Test Guideline 810.2000 (general considerations for testing antimicrobial products) and the reregistration efficacy guidance document athttp://www.epa.gov/oppad001/reregistration-efficacy-standards.pdf for additional information.The following footnotes are referenced in column two (5. Study Title) of the Requirements Status and Registrant's Response form. These footnotes apply in addition to anytest notes included in 40 CFR Part 158 with respect to the particular data requirementCase # and Name:DCI Number:PDCI-107403-30541Page 5 of 5Footnotes:Key:United States Environmental ProtectionAgency Washington, D.C. 20460FOOTNOTES AND KEY DEFINITIONS FOR GUIDELINE REQUIREMENTSEP; MP; TGAI = End Use Product; Manufacturing Use Product; Technical Grade Active Ingredient; MP; TGAI = Manufacturing Use Product; Technical Grade Active Ingredient; EP; MP = End UseProduct, Manufacturing Use Product; EP = End Use Product [EP]; TGAI = Technical Grade Active Ingredient [TGAI]; EP; TGAI = EndUse Product; Technical Grade Active IngredientUse Categories Key:T -U -X -Commercial, institutional and indResidential and public access prMaterials preservatives39Refer to the Product Performance Test Guideline 810.2000 (general considerations for testing antimicrobial products) and the reregistration efficacy guidance document athttp://www.epa.gov/oppad001/reregistration-efficacy-standards.pdf for additional information.40Refer to the Product Performance Test Guideline 810.2000 (general considerations for testing antimicrobial products) and the reregistration efficacy guidance document athttp://www.epa.gov/oppad001/reregistration-efficacy-standards.pdf for additional information.